Skip to content
Certified ManufacturersFor manufacturers

Yerba Prima, Inc.

Ashland, OR, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Yerba Prima, Inc. is a dietary supplement manufacturer in Ashland, OR, United States, certified to NSF/ANSI 455-2 GMP, with 2 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules and powders.

Facilities listed
4
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (2)

  • 740 Jefferson Avenue, Ashland, OR 97520, United States

    • Dry Formulation
    • Encapsulation
    • Kits
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Quality Unit Operations
    • Warehousing
  • 724 Jefferson Ave, Ashland, OR 97520, United States

    • Warehousing

Distribution (2)

  • 722 Jefferson Avenue, Ashland, OR 97520, United States

    • Quality Unit Operations
    • Warehousing
  • 724 Jefferson Ave, Ashland, OR 97520, United States

    • Warehousing

How Yerba Prima, Inc. compares

Among the 769 manufacturers we list, as of our last check.

  • One of 5 capsule manufacturers we list in Oregon, and 325 in the United States. All capsule manufacturers in the USA · All in Oregon
  • One of 4 powder manufacturers we list in Oregon, and 316 in the United States. All powder manufacturers in the USA
  • NSF lists kitting at one of its facilities, an operation listed for 61 of the 769 manufacturers we list.
  • Has 2 listed manufacturing or packaging facilities; 71% of the manufacturers we list have fewer.

FDA recall records

FDA lists 1 recall matching the name Yerba Prima, Inc., as of .

  • Class II · Could cause temporary or reversible health problems

    Reported

    Closed by FDA

    Potential contamination with Pseudomonas aeruginosa.

    Product: Great Plains Bentonite + Herbal Detox Capsules 60 capsules, packaged in PETE amber bottle, white plastic cap and tamper proof seal. Case GTIN code:100 46352 0…

    Full product description
    • Great Plains Bentonite + Herbal Detox Capsules 60 capsules, packaged in PETE amber bottle, white plastic cap and tamper proof seal. Case GTIN code:100 46352 00518 5. Retail package UPC code: 0 46352 00518 8. Yerba Prima, Inc. 740 Jefferson Ave Ashland, Oregon 97520 USA
    openFDA record

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 4 food or dietary supplement inspections at facilities matching Yerba Prima, Inc., from 2014 to 2025, as of . 1 found no objectionable conditions and 3 found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Ashland, Oregon

    6 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))
    • Quality control - batch released, adulteration (21 CFR 111.123(b)(3))
    See all 6 citations
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish limits on contamination to ensure the quality of the dietary supplement.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity, strength, composition and limits on contamination.

    • Quality control - reject; specification not met (21 CFR 111.113(b)(2))

      Your quality control personnel did not reject a dietary supplement when an established specification was not met.

    • Quality control - batch released, adulteration (21 CFR 111.123(b)(3))

      Your quality control personnel approved and released for distribution a batch of dietary supplement that was not manufactured, packaged, labeled, or held under conditions to prevent adulteration.

    • Master manufacturing record - prepared (21 CFR 111.205(a))

      You did not prepare a written master manufacturing record for each batch size of a dietary supplement that you manufactured.

    • Batch record - required information (21 CFR 111.260)

      Your batch production record did not include all required information.

    FEI 1000126716

  • No action indicated · No objectionable conditions found

    Inspected

    Ashland, Oregon

    FEI 1000126716

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Ashland, Oregon

    4 citations posted:

    • Procedures - calibrating automated, mechanical equip (21 CFR 111.25(b))
    • Documentation - supplier qualification (21 CFR 111.95(b)(2))
    • Quality control master manufacturing record; material review, disposition (21 CFR 111.113(a)(2))
    • Batch record - date, time; maintenance (21 CFR 111.260(b))
    Full citation text
    • Procedures - calibrating automated, mechanical equip (21 CFR 111.25(b))

      You did not follow written procedures for calibrating, inspecting, and checking automated, mechanical, and electronic equipment.

    • Documentation - supplier qualification (21 CFR 111.95(b)(2))

      You did not make and keep documentation of your qualification of a supplier.

    • Quality control master manufacturing record; material review, disposition (21 CFR 111.113(a)(2))

      Your quality control personnel did not conduct a material review and make a disposition decision when a batch deviated from the master manufacturing record.

    • Batch record - date, time; maintenance (21 CFR 111.260(b))

      Your batch production records did not include the identity of equipment and processing lines used in producing the batch.

    FEI 1000126716

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Ashland, Oregon

    6 citations posted:

    • Packaging description, representative label (21 CFR 111.210(g))
    • Master manufacturing record - sampling, tests, examinations (21 CFR 111.210(h)(2))
    • Master manufacturing record - specific actions; quality (21 CFR 111.210(h)(3))
    • Batch record - results; testing, examination; batch (21 CFR 111.260(h))
    See all 6 citations
    • Packaging description, representative label (21 CFR 111.210(g))

      Your master manufacturing record did not include a a representative label, or a cross-reference to the physical location of the actual or representative label.

    • Master manufacturing record - sampling, tests, examinations (21 CFR 111.210(h)(2))

      The written instructions in your master manufacturing record did not include procedures for sampling and a cross-reference to procedures for tests or examinations.

    • Master manufacturing record - specific actions; quality (21 CFR 111.210(h)(3))

      The written instructions in your master manufacturing record did not include specific actions necessary to perform and verify points, steps, or stages in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.

    • Batch record - results; testing, examination; batch (21 CFR 111.260(h))

      Your batch production records did not include the results of testing or examination performed during batch production, or a cross-reference to such results.

    • Batch record - label (21 CFR 111.260(k)(2))

      Your batch production records did not include an actual or representative label, or a cross-reference to the physical location of the actual or representative label specified in the master manufacturing record.

    • Packaging, labels - master manufacturing record (21 CFR 111.410(c))

      You did not examine, before labeling operations, labels for each batch of dietary supplement to determine whether the labels conformed to the master manufacturing record.

    FEI 1000126716

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 4 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026